|
Eli Perencevich, MD, MS
Eli Perencevich, MD, MS
Maryland VA
Baltimore, MD
Find citations from this investigator | Find recent studies by this investigator
Dr. Perencevich received a BS in Economics at the University of Michigan, Ann Arbor in 1990. He received his MD from Case Western Reserve University in 1994, completed his internal medicine internship and residency at The New York Hospital-Cornell Medical Center in June 1997 and was chief medical resident at New York University Downtown Hospital from 1997 to 1998. He was a research and clinical fellow in infectious diseases at Beth Israel Deaconess Medical Center of Harvard University from 1998 to 2001. During his fellowship, he completed a Master's of Science in Epidemiology at the Harvard School of Public Health. He joined the VA in 2001.
Dr. Perencevich's major research interest is the use of mathematical modeling and decision analysis techniques to guide medical decision-making in the methods of prevention of patient-to-patient transmission of antibiotic-resistant bacteria. In particular he has developed hospital and community level mathematical models to help understand the epidemiology of vancomycin resistant enterococci (VRE) and develop cost-effective methods to control this resistant bacteria's spread. With colleagues at the Maryland VA, he developed and secured funding for a project to develop prediction rules to identify high-risk patients for VRE colonization and expand existing mathematical models to test cost-effective methods to control the spread of VRE in a VA hospital. Work on that study, HSR&D Project RCD 02026-1, will allow him to advance his knowledge and understanding of the epidemiology of VRE and assess optimal methods for its control. Dr. Perencevich also plans to receive additional course-work training in applied mathematics during his HSR&D career development award.
Dr. Perencevich has had 13 manuscripts published or accepted for publication in 2003 and 2004 including "Acceptable Treatment Failure Rates in Osteomyelitis Involving the Diabetic Foot: A Survey of Infectious Disease Physicians," and "Projected Benefits of Active Surveillance for Vancomycin-Resistant Enterococci in ICU Settings," which are to be in upcoming issues of Clinical Infectious Diseases. He was recently appointed to two national committee positions: The USDA - National Advisory Committee on Microbiological Criteria for Foods and the CDC Healthcare Infection Control Practices Advisory Committee's (HICPAC) Surveillance Working Group.
Dr. Perencevich's mentors are Douglas Bradham, PhD, a nationally recognized healthcare economist and J. Glenn Morris, MD, MPH, a nationally recognized infectious disease epidemiologist.
|
